Otago glaucoma surgery outcome study: The pattern of expression of mmps and timps in bleb capsules surrounding molteno implants

Investigative Ophthalmology and Visual Science

Volumn 50, Issue 5, 2009, Pages 2161-2164

  McCluskey, Peter ^a,b   Molteno, Anthony ^c   Wakefield, Denis ^b   Di Girolamo, Nick ^b  

^a LIVERPOOL HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; BETAMETHASONE; COLCHICINE; COLLAGEN; DIPIVEFRINE; GELATINASE A; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; NONSTEROID ANTIINFLAMMATORY AGENT; STROMELYSIN; TIMOLOL; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3;

ADULT; AGED; APOPTOSIS; ARTICLE; BLEB CAPSULE; CLINICAL ARTICLE; CLINICAL FEATURE; COLLAGEN DEGRADATION; CORRELATION ANALYSIS; CYTOPLASM; DEGENERATION; FEMALE; FIBROBLAST; GLAUCOMA; GLAUCOMA SURGERY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMPLANT; MALE; MONTENO IMPLANT; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN LOCALIZATION; TREATMENT OUTCOME; BLISTER; CONJUNCTIVA; CONNECTIVE TISSUE; DONOR; ENZYME IMMUNOASSAY; ENZYMOLOGY; GLAUCOMA DRAINAGE IMPLANT; METABOLISM; MIDDLE AGED;

ADULT; AGED; AGED, 80 AND OVER; BLISTER; COLLAGEN; CONJUNCTIVA; CONNECTIVE TISSUE; CYTOPLASM; FEMALE; FIBROBLASTS; GLAUCOMA; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MATRIX METALLOPROTEINASES; MIDDLE AGED; MOLTENO IMPLANTS; TISSUE DONORS; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 65549138578     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.08-2063     Document Type: Article

References (18)

1. Sung VCT, Barton K. Management of inflammatory glaucomas. Curr Opin Ophthalmol. 2004;15:136-140.
2. Molteno AC, Fucik M, Dempster AG, Bevin TH. Otago glaucoma surgery outcome study: factors controlling capsule fibrosis around Molteno implants with histopathological correlation. Ophthalmol ogy. 2003;110:2198-2206.
3. Molteno AC, Suter AJ, Fenwick M, Bevin TH, Dempster AG. Otago glaucoma surgery outcome study: cytology and immunohisto- chemical staining of bleb capsules around Molteno implants. In- vest Ophthalmol Vis Sci. 2006;47:1975-1981.
4. Nagase H, Visse R, Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res. 2006;69:562-573.
5. Opdenakker G, Van den Steen PE, Van Damme J. Gelatinase B: a tuner and amplifier of immune functions. Trends Immunol. 2001; 22:571-579.
6. Elliot S, Catanuto P, Stetler-Stevenson W, Cousins SW. Retinal pigment epithelium protection from oxidant-mediated loss of MMP-2 activation requires both MMP-14 and TIMP-2. Invest Ophthalmol Vis Sci. 2006;47:1696-1702.
7. Hayakawa T, Yamashita K, Ohuchi E, Shinagawa A. Cell growth-promoting activity of tissue inhibitor of metalloproteinases-2 (TIMP-2). J Cell Sci. 1994;107:2373-2379.
8. Lim MS, Guedez L, Stetler-Stevenson WG, Stetler-Stevenson M. Tissue inhibiter of matrix metalloproteinase-2 induces apoptosis in human T lymphocytes. Ann NY Acad Sci. 1999;878:522-523.
9. Di Girolamo N, McCluskey PJ, Lloyd A, Coroneo M, Wakefield D. Expression of MMPs and TIMPs in human pterygia and cultured pterygium epithelial cells. Invest Ophthalmol Vis Sci. 2000;41: 671-679.
10. Di Girolamo N, Wakefield D, Coroneo MT. Differential expression of matrix metalloproteinases and their inhibitors at the advancing pterygium head. Invest Ophthalmol Vis Sci. 2000;41:4142-4149.
11. Di Girolamo N, Coroneo MT, Wakefield D. Active matrilysin/MMP-7 in human pterygia: potential role in angiogenesis. Invest Ophthalmol Vis Sci. 2001;42:1963-1968.
12. Hettiaratchi A, Hawkins NJ, Ward RL, Hunt JE, Wakefield D, Di Girolamo N. The collagenase (MMP-1) gene promoter polymorphism 1607/2G is associated with favorable prognosis in patients with colorectal cancer. Br J Cancer. 2007;96:783-792.
13. Esson DW, Popp MP, Liu L, Schultz GS, Sherwood MB. Microarray analysis of the failure of filtering blebs in a rat model of glaucoma filtering surgery. Invest Ophthalmol Vis Sci. 2004;45:4450-4462.
14. DiGirolamo N, Lloyd A, McCluskey PJ, Filipic M, Wakefield D. Increased expression of matrix metalloproteinases in vivo in scle- ritis tissue and in vitro in cultured human scleral fibroblasts. Am J Pathol. 1997;150:653-666.
15. Wu W, Billinghurst RC, Pidoux I, et al. Sites of collagenase cleavage and denaturation of type II collagen in aging and osteoarthritic articular cartilage and their relationship to the distribution of matrix metalloproteinase 1 and matrix metalloproteinase 13. Arthritis Rheum. 2002;46:2087-2094.
16. Garcia-Touchard A, Henry TD, Sangiorgi G. Extracellular proteases in atherosclerosis and restenosis. Arterioscler Thromb Vasc Biol. 2005;25:1119-1127.
17. Forrester JV, Dick AD, McMenamin P, Lee WR. The aqueous. In: The Eye: Basic Sciences in Clinical Practice. London: WB Saunders; 1996:P169.
18. Duke-Elder S, Gloster J. The physiology of the eye. In: Duke-Elder S, ed. System of Ophthalmology. Vol 4. London; Henry Kimpton; 1968:3-432.